Private company
Venrock Healthcare Capital Partners III, L.P.
Fund registered in the United States, based in New York, active since 2018. Summary from the record
Last updated Oct 21, 2026.
Overview
Corporate structure
Venrock Healthcare Capital Partners III, L.P. sits at the top of its group. 51 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- Venrock Healthcare Capital Partners III, L.P. New York, New York, United States
- 4D Molecular Therapeutics, Inc. Stake · Emeryville, California
- Abivax S.A. Stake · I0
- ACHIEVE LIFE SCIENCES, INC. Stake · Bothell, Washington, United States
- Adlai Nortye Group Ltd. Stake · DE
- Aeglea BioTherapeutics Stake · Austin
- Ambrx Biopharma Cayman, Inc. Stake · La Jolla, California
- Ambrx Biopharma, Inc. Stake · La Jolla, California
- Apogee Therapeutics, Inc. Stake · San Francisco, California
- Applied Therapeutics, Inc. Stake · New York, New York, United States
- Aquestive Therapeutics, Inc. Stake · Warren, New Jersey
- Artiva Biotherapeutics, Inc. Stake · San Diego, California
- Avalanche Biotechnologies Stake · Redwood City
- Avalo Therapeutics, Inc. Stake · Wayne, Pennsylvania
- Cabaletta Bio, Inc. Stake · Philadelphia, Pennsylvania
- CASI Pharmaceuticals, Inc. Stake · Beijing, China
- Catabasis Pharmaceuticals Stake · Cambridge
- Celcuity Inc. Stake · Minneapolis, Minnesota, United States
- Century Therapeutics (United States) Stake · Philadelphia, Pennsylvania
- Cidara Therapeutics Stake · San Diego, California, United States
- CRESCENT BIOPHARMA, INC. Stake · Waltham, Massachusetts
- CytomX Therapeutics, Inc. Stake · South San Francisco, California, United States
- Damora Therapeutics, Inc. Stake · Waltham, Massachusetts
- enGene Therapeutics Inc. Stake · Z4
- Enliven Therapeutics, Inc. Stake · Burlingame, California
- Erasca, Inc. Stake · San Diego, California
- and 25 more
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (50 companies). Each entity in the chart links to its source.
Timeline
- Apr 3, 2018Founded Venrock Healthcare Capital Partners III, L.P. is founded2
Stakes it holds
Venrock Healthcare Capital Partners III, L.P. has told the SEC it owns more than 5% of 50 companies, latest first (Schedules 13D and 13G).
- X4 Pharmaceuticals, IncSCHEDULE 13G Sep 21, 20263
- Korsana Biosciences, Inc.SCHEDULE 13D Sep 15, 20264
- Apogee Therapeutics, Inc.SCHEDULE 13D/A Jul 28, 2023 to Sep 8, 20265
- Adlai Nortye Group Ltd.SCHEDULE 13G/A Feb 11, 2026 to Aug 14, 20266
- Artiva Biotherapeutics, Inc.SCHEDULE 13G/A Aug 1, 2024 to Aug 14, 20267
- Jade Biosciences, Inc.SCHEDULE 13G/A May 5, 2025 to Aug 14, 20268
- KalVista Pharmaceuticals, Inc.SCHEDULE 13G/A Jan 9, 2023 to Aug 14, 20269
- Oruka Therapeutics, Inc.SCHEDULE 13G/A Apr 29, 2024 to Aug 14, 202610
- TENAX THERAPEUTICS, INC.SCHEDULE 13G/A Aug 19, 2024 to Aug 14, 202611
- Vor Biopharma Inc.SCHEDULE 13G/A Sep 25, 2025 to Aug 14, 202612
- enGene Therapeutics Inc.SCHEDULE 13G/A Feb 26, 2024 to Aug 14, 202613
- RELMADA THERAPEUTICS, INC.SCHEDULE 13G Jun 9, 202614
- CytomX Therapeutics, Inc.SCHEDULE 13G/A May 20, 2025 to May 15, 202615
- Enliven Therapeutics, Inc.SCHEDULE 13G/A Mar 13, 2023 to May 15, 202616
- Erasca, Inc.SCHEDULE 13G/A May 31, 2024 to May 15, 202617
- Oric Pharmaceuticals, Inc.SCHEDULE 13G/A Feb 1, 2024 to May 15, 202618
- Surrozen, Inc./DESCHEDULE 13G/A Apr 2, 2025 to May 15, 202619
- Zura Bio LtdSCHEDULE 13G/A May 2, 2024 to May 15, 202620
- ACHIEVE LIFE SCIENCES, INC.SCHEDULE 13G Apr 24, 202621
- Korro Bio, Inc.SCHEDULE 13G Mar 17, 202622
- CASI Pharmaceuticals, Inc.SCHEDULE 13G/A Jul 25, 2024 to Feb 17, 202623
- CRESCENT BIOPHARMA, INC.SCHEDULE 13G/A Jun 23, 2025 to Feb 17, 202624
- Damora Therapeutics, Inc.SCHEDULE 13G Feb 17, 202625
- Freenome, Inc.SCHEDULE 13G/A Jun 24, 2024 to Feb 17, 202626
- OCULAR THERAPEUTIX, INCSCHEDULE 13G/A Dec 28, 2023 to Feb 17, 202627
- Savara IncSCHEDULE 13G/A Jul 8, 2025 to Feb 17, 202628
- Century Therapeutics (United States)SCHEDULE 13G Mar 4, 2024 to Jan 16, 202629
- Abivax S.A.SCHEDULE 13G/A Nov 22, 2023 to Nov 14, 202530
- Helus Pharma Inc.SCHEDULE 13G Nov 7, 202531
- Cidara TherapeuticsSCHEDULE 13G/A Dec 4, 2024 to Aug 14, 202532
All 50 companies
- Magenta TherapeuticsSCHEDULE 13G/A Sep 21, 2023 to Aug 14, 202533
- Pharvaris N.V.SCHEDULE 13G/A Nov 30, 2023 to Aug 14, 202534
- 4D Molecular Therapeutics, Inc.SCHEDULE 13G/A May 15, 2023 to May 15, 202535
- Applied Therapeutics, Inc.SCHEDULE 13G/A May 8, 2023 to May 15, 202536
- Mersana Therapeutics (United States)SCHEDULE 13G/A Aug 7, 2023 to May 15, 202537
- Praxis Precision Medicines, Inc.SCHEDULE 13G/A Jun 30, 2023 to May 15, 202538
- Aeglea BioTherapeuticsSCHEDULE 13G/A Jul 10, 2023 to Feb 14, 202539
- Aquestive Therapeutics, Inc.SCHEDULE 13G/A Apr 1, 2024 to Feb 14, 202540
- Avalanche BiotechnologiesSCHEDULE 13G/A Jul 24, 2023 to Feb 14, 202541
- Catabasis PharmaceuticalsSCHEDULE 13G/A Jan 2, 2024 to Feb 14, 202542
- Viridian Therapeutics, Inc.\DESCHEDULE 13G/A Oct 14, 2021 to Feb 14, 202543
- Cabaletta Bio, Inc.SC 13G/A Dec 23, 2022 to Nov 14, 202444
- Celcuity Inc.SC 13G/A Feb 14, 2024 to Nov 14, 202445
- Taysha Gene Therapies, Inc.SC 13G/A Aug 28, 2023 to Nov 14, 202446
- Terns Pharmaceuticals, Inc.SC 13G/A Aug 29, 2022 to Nov 14, 202447
- Ambrx Biopharma, Inc.SC 13G/A Feb 14, 202448
- Avalo Therapeutics, Inc.SC 13G/A Feb 17, 2023 to Feb 14, 202449
- Milestone Pharmaceuticals Inc.SC 13G/A Sep 20, 2022 to Feb 14, 202450
- RayzeBio, Inc.SC 13G/A Sep 29, 2023 to Feb 14, 202451
- Ambrx Biopharma Cayman, Inc.SC 13G Feb 27, 202352
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52